Cannabis Hyperemesis Syndrome Gains Global Recognition

The World Health Organization has assigned an official diagnostic code for Cannabinoid Hyperemesis Syndrome, formalizing global recognition of the condition and facilitating research into the rare but severe disorder.

The ICD (International Classification of Diseases) code standardizes how CHS is identified and documented across healthcare systems worldwide—a significant step for a condition that was first described only two decades ago.

What Is CHS?

Cannabinoid Hyperemesis Syndrome causes cyclical episodes of severe nausea, vomiting, and abdominal pain in some long-term cannabis users. The condition is paradoxical because cannabis is typically used to treat nausea, not cause it.

A distinctive symptom: many patients find temporary relief from hot showers or baths, a behavior pattern that helps clinicians diagnose CHS. But the only proven long-term cure is stopping cannabis use entirely.

First documented in 2004, CHS remained largely unknown outside emergency medicine until recently. As cannabis use has increased with legalization, more cases are being recognized and diagnosed.

The Diagnostic Code

Assigning an ICD code has several practical effects:

• Hospitals and doctors can officially document CHS in medical records
• Insurance companies can track the condition and reimbursement
• Researchers can identify CHS cases in medical databases for epidemiological studies
• Public health officials can monitor prevalence and trends

Before the code existed, CHS was often misdiagnosed or documented under more generic categories like "cyclical vomiting syndrome" or "nausea and vomiting."

Rising Incidence

Emergency departments in states with legal cannabis have reported increases in CHS cases as marijuana use has grown and products have become more potent.

Estimates suggest 2-3% of regular cannabis users may experience CHS, though true prevalence is uncertain. Many cases likely go undiagnosed because patients don't mention cannabis use or doctors don't consider CHS.

The formal diagnostic code should improve case identification and help researchers better understand who's at risk and what factors contribute to developing the condition.

Industry Implications

For the cannabis industry, CHS represents an education challenge. Consumers should understand that while cannabis is relatively safe for most users, chronic high-dose consumption can cause health issues in some people.

Companies may need to develop consumer guidance around product potency, usage patterns, and potential risks—similar to responsible consumption messaging in the alcohol industry competition.

---

This article is based on original reporting by AOL.